• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶抑制剂强化高效抗逆转录病毒疗法对HIV-1感染患者口腔病损患病率的影响。一项希腊的研究。

Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study.

作者信息

Nicolatou-Galitis O, Velegraki A, Paikos S, Economopoulou P, Stefaniotis T, Papanikolaou I S, Kordossis T

机构信息

Department of Oral Pathology and Oral Medicine, School of Dentistry, National and Kapodistrian University of Athens, Athens, Greece.

出版信息

Oral Dis. 2004 May;10(3):145-50. doi: 10.1046/j.1601-0825.2003.00994.x.

DOI:10.1046/j.1601-0825.2003.00994.x
PMID:15089923
Abstract

OBJECTIVE

To investigate the association between the prevalence of oral lesions and highly active antiretroviral therapy (HAART) including a protease inhibitor (PI).

DESIGN

Prospective study.

PATIENTS AND METHODS

Ninety-five consecutive patients, attending an AIDS Unit, in Greece entered the study. Fourty-four patients were receiving PI- HAART, 14 patients were on double antiretroviral therapy, and 37 patients were not receiving antiretroviral therapy at the time of oral examination. Oral lesions were diagnosed by established presumptive clinical criteria.

MAIN OUTCOME MEASURES

Oral lesions were scored. CD4 counts and viral load were determined and related to the prevalence of oral lesions.

RESULTS

Oral lesions, and specifically oral candidiasis, were significantly reduced (P < 0.001) in patients receiving PI-HAART. Oral lesions were significantly increased in patients with CD4 counts <200 cells microl(-1) and viral load >20,000 copies ml(-1) (P < 0.001). The percentage of patients, with lesions on PI-HAART, and with CD4 < 200 and viral load >20,000 was 1.5 times lower (37.5%vs 58.8%, P < 0.001) than that of patients not receiving antiretroviral therapy, but with similar immune and viremic status.

CONCLUSIONS

Oral lesions were significantly reduced in patients on PI-HAART. A direct anticandidal effect of PI was suggestive and seemed to have accounted, beyond the HAART-related immune reconstitution, for the reduction of candidiasis and all other oral lesions.

摘要

目的

研究包括蛋白酶抑制剂(PI)在内的高效抗逆转录病毒疗法(HAART)与口腔病损患病率之间的关联。

设计

前瞻性研究。

患者与方法

希腊一家艾滋病治疗中心的95例连续就诊患者纳入本研究。44例患者接受含PI的HAART治疗,14例患者接受双重抗逆转录病毒治疗,37例患者在口腔检查时未接受抗逆转录病毒治疗。根据既定的临床初步标准诊断口腔病损。

主要观察指标

对口腔病损进行评分。测定CD4细胞计数和病毒载量,并分析其与口腔病损患病率的关系。

结果

接受含PI的HAART治疗的患者口腔病损,尤其是口腔念珠菌病显著减少(P<0.001)。CD4细胞计数<200个/微升且病毒载量>20,000拷贝/毫升的患者口腔病损显著增加(P<0.001)。接受含PI的HAART治疗、CD4<200且病毒载量>20,000的患者病损发生率比未接受抗逆转录病毒治疗但免疫和病毒血症状态相似的患者低1.5倍(37.5%对58.8%,P<0.001)。

结论

接受含PI的HAART治疗的患者口腔病损显著减少。PI对念珠菌有直接抗菌作用,这一作用具有提示意义,且似乎除了与HAART相关的免疫重建外,还促成了念珠菌病和所有其他口腔病损的减少。

相似文献

1
Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study.蛋白酶抑制剂强化高效抗逆转录病毒疗法对HIV-1感染患者口腔病损患病率的影响。一项希腊的研究。
Oral Dis. 2004 May;10(3):145-50. doi: 10.1046/j.1601-0825.2003.00994.x.
2
Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.基于蛋白酶抑制剂(PI)和非核苷类逆转录酶抑制剂(NNRTI)的高效抗逆转录病毒疗法(HAART)对巴西HIV感染患者口腔病变的影响。
J Oral Pathol Med. 2009 Jul;38(6):489-94. doi: 10.1111/j.1600-0714.2009.00783.x. Epub 2009 Apr 28.
3
The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study.抗逆转录病毒疗法对HIV感染患者口腔表现患病率的影响:一项英国研究。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Dec;92(6):623-8. doi: 10.1067/moe.2001.118902.
4
Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.口腔病变作为高效抗逆转录病毒治疗失败的临床标志物:墨西哥城的一项巢式病例对照研究。
Clin Infect Dis. 2007 Oct 1;45(7):925-32. doi: 10.1086/521251. Epub 2007 Aug 23.
5
Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.塞尔维亚和黑山接受高效抗逆转录病毒治疗的艾滋病毒感染患者的长期生存情况。
HIV Med. 2007 Mar;8(2):75-9. doi: 10.1111/j.1468-1293.2007.00429.x.
6
Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients.口腔念珠菌病和口腔毛状白斑作为巴西HIV感染患者高效抗逆转录病毒治疗失败的预测指标。
Oral Dis. 2006 Jul;12(4):402-7. doi: 10.1111/j.1601-0825.2005.01214.x.
7
A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load.一项随机对照试验,旨在研究病毒载量检测不到的患者从蛋白酶抑制剂转换为奈韦拉平的疗效和安全性。
HIV Med. 2005 Sep;6(5):353-9. doi: 10.1111/j.1468-1293.2005.00320.x.
8
Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy.联合抗逆转录病毒治疗时代机会性胃肠道疾病患病率的下降
Am J Gastroenterol. 2000 Feb;95(2):457-62. doi: 10.1111/j.1572-0241.2000.01768.x.
9
The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.接受抗逆转录病毒治疗3年后病毒载量无法检测的患者每日一次服用沙奎那韦/利托那韦的48周疗效。
HIV Med. 2005 Mar;6(2):122-8. doi: 10.1111/j.1468-1293.2005.00274.x.
10
Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.丙型肝炎病毒(HCV)病毒血症和HCV基因型在一组未接受过抗逆转录病毒治疗的HIV感染个体接受高效抗逆转录病毒治疗后的免疫恢复中的作用。
Clin Infect Dis. 2005 Jun 15;40(12):e101-9. doi: 10.1086/430445. Epub 2005 May 5.

引用本文的文献

1
Prevalence of dental caries and associated risk factors among People Living with HIV/AIDS and HIV uninfected adults at an HIV clinic in Kigali, Rwanda.卢旺达基加利一家艾滋病病毒诊所中艾滋病病毒感染者/艾滋病患者和未感染艾滋病病毒的成年人的龋齿患病率及其相关危险因素。
PLoS One. 2023 Apr 6;18(4):e0276245. doi: 10.1371/journal.pone.0276245. eCollection 2023.
2
Comparative Efficacy and Safety of Antifungal Agents in the Prophylaxis of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis.抗真菌药物在预防HIV感染成人口腔念珠菌病中的疗效和安全性比较:一项系统评价和网状Meta分析
Life (Basel). 2022 Mar 31;12(4):515. doi: 10.3390/life12040515.
3
A Real-world Evidence-based Management of HIV by Differential Duration HAART Treatment and its Association with Incidence of Oral Lesions.
基于真实世界证据的 HIV 差异化时长 HAART 治疗管理及其与口腔病变发生率的关联。
Curr HIV Res. 2022;20(1):91-99. doi: 10.2174/1570162X20666211227154558.
4
Oral health related quality of life among HIV positive patients attending two HIV outpatient clinics in Nigeria - a cross sectional study.尼日利亚两家艾滋病毒门诊就诊的艾滋病毒阳性患者的口腔健康相关生活质量 - 一项横断面研究。
Afr Health Sci. 2021 Jun;21(2):566-575. doi: 10.4314/ahs.v21i2.11.
5
Stage II and stage III periodontitis clinical burdens of HIV-1 undergoing antiretroviral therapy.抗逆转录病毒治疗的 HIV-1 患者的牙周炎 II 期和 III 期的临床负担。
Clin Oral Investig. 2022 Feb;26(2):2187-2195. doi: 10.1007/s00784-021-04201-2. Epub 2021 Oct 3.
6
Comparative Efficacy of Antifungal Agents Used in the Treatment of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis.抗真菌药物治疗HIV感染成人口腔念珠菌病的疗效比较:一项系统评价和网状Meta分析
J Fungi (Basel). 2021 Aug 5;7(8):637. doi: 10.3390/jof7080637.
7
Dental caries status of children receiving Highly active antiretroviral therapy (HAART) - A multicentric cross-sectional study in Tamil Nadu, India.接受高效抗逆转录病毒疗法(HAART)的儿童的龋齿状况——印度泰米尔纳德邦的一项多中心横断面研究。
J Family Med Prim Care. 2020 Dec 31;9(12):6147-6152. doi: 10.4103/jfmpc.jfmpc_1032_20. eCollection 2020 Dec.
8
Oral health status and treatment needs among HIV/AIDS patients attending antiretroviral therapy center in Western India: A cross-sectional study.印度西部接受抗逆转录病毒治疗的艾滋病患者的口腔健康状况及治疗需求:一项横断面研究。
J Family Med Prim Care. 2020 Jul 30;9(7):3722-3728. doi: 10.4103/jfmpc.jfmpc_411_20. eCollection 2020 Jul.
9
A real-world, cross sectional study of oral lesions and their association with CD4 cell counts and HIV viral load in Yunnan, China.中国云南口腔病变及其与CD4细胞计数和HIV病毒载量相关性的一项真实世界横断面研究。
Medicine (Baltimore). 2020 Oct 2;99(40):e22416. doi: 10.1097/MD.0000000000022416.
10
Significant effect of HIV/HAART on oral microbiota using multivariate analysis.使用多变量分析发现 HIV/HAART 对口腔微生物群有显著影响。
Sci Rep. 2019 Dec 27;9(1):19946. doi: 10.1038/s41598-019-55703-9.